title: P2X4 receptor expression in a rat model of trigeminal neuropathic pain.
abstract: We investigated the P2X4 receptor (P2X4R) expression in the cervical spinal cord, trigeminal ganglion, and infraorbital nerve (ION), after a chronic constriction injury of unilateral ION and a treatment with selective serotonin reuptake inhibitor (SSRI). A recent study has showed that SSRI inhibits P2X4R expression. Injured rats had significantly lower pain thresholds. In injured and slightly injured ION, the P2X4R expression was significantly higher than in the naïve-rat ION. Injured animals with SSRI showed significantly higher pain thresholds than injured animals without the drug. Nonetheless, P2X4R expression in the ipsilateral ION remained high. Immunostaining showed that macrophages are the source of P2X4R. Our results suggest that the expression of P2X4R in our model is modulated not by neuropathic pain, but by slight nerve injury.
authors.affiliation: Department of Plastic and Reconstructive Surgery, Osaka Medical College, Takatsuki, Japan. ckadn610@sutv.zaq.ne.jp
authors.forename: Kunihiro
authors.initials: K
authors.lastname: Nakai
authors.forename: Aya
authors.initials: A
authors.lastname: Nakae
authors.forename: Sosuke
authors.initials: S
authors.lastname: Oba
authors.forename: Takashi
authors.initials: T
authors.lastname: Mashimo
authors.forename: Koichi
authors.initials: K
authors.lastname: Ueda
mesh_terms: D000344:Afferent Pathways / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D004195:Disease Models, Animal; D007150:Immunohistochemistry; D008026:Ligation / Q000009:adverse effects; D008264:Macrophages / Q000166:cytology / Q000378:metabolism; D008297:Male; D008442:Maxillary Nerve / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D009619:Nociceptors / Q000187:drug effects / Q000378:metabolism; D010147:Pain Measurement; D017288:Pain Threshold / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018048:Receptors, Purinergic P2 / Q000187:drug effects / Q000378:metabolism*; D058848:Receptors, Purinergic P2X4; D011984:Sensory Receptor Cells / Q000187:drug effects / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D014275:Trigeminal Caudal Nucleus / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D012668:Trigeminal Ganglion / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D014276:Trigeminal Nerve / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D014277:Trigeminal Neuralgia / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology*
chemical_list: D018048:Receptors, Purinergic P2; D058848:Receptors, Purinergic P2X4; D017367:Selective Serotonin Reuptake Inhibitors; C548228:P2rx4 protein, rat